We build regulated digital medicine to change the trajectory of advanced liver disease, one of the world's fastest-growing health burdens.
CyberLiver emerged from a conversation between our co-founders about the huge and growing burden of liver disease, and how poorly it is served by episodic, hospital-centred care.
We are assembling a world-class team of experts across clinical strategy, software, regulatory, intellectual property and commercial, united by one aim: to keep patients well at home and change outcomes at scale.
Professor of Hepatology and Head of the Liver Failure Group at UCL, and consultant hepatologist at the Royal Free Hospital, London.
Hepatologists, engineers, data scientists and regulatory specialists building medicine-grade software together.
Our work is supported by NHS collaborations, NIHR-funded research and Innovate UK, with RCT-backed evidence.
We're always looking for people who want to help re-invent liver care.
See open roles